XML 33 R22.htm IDEA: XBRL DOCUMENT

Acquisition (Table)

3 Months Ended

Sep. 30, 2021

Acquisition

Schedule Of assets and liabilities of Infusionz

Tangible Assets		$	860,738
Intangible Assets			1,624,000
Goodwill			1,271,780
Liabilities Acquired			(199,929	)
Total Purchase Price		$	3,556,589

Schedule of pro forma

Pro Forma, Unaudited										Proforma
Three months ended September 30, 2021		Grove, Inc.				VitaMedica				Adjustments				Proforma

Net sales		$	8,449,754			$	384,391							$	8,834,145
Cost of sales		$	3,067,376			$	93,509							$	3,160,885
Operating expenses		$	4,946,835			$	255,286			$	34,417			$	5,236,538
Net income (loss)		$	511,711			$	35,596				(34,417	)		$	512,890
Basic income per common share		$	0.03			$	0.36							$	0.03
Weighted average shares outstanding			15,452,453				100,000								15,552,453

Pro Forma, Unaudited										Proforma
Three months ended September 30, 2020		Grove, Inc.				VitaMedica				Adjustments				Proforma

Net sales		$	2,937,442			$	874,290							$	3,811,732
Cost of sales		$	1,619,208			$	245,628							$	1,864,836
Operating expenses		$	2,078,320			$	553,965			$	103,250			$	2,735,535
Net income (loss)		$	(809,073	)		$	74,696				(103,250	)		$	(837,627	)
Basic income (loss) per common share		$	(0.08	)		$	0.75							$	(0.08	)
Weighted average shares outstanding			10,384,439				100,000								10,484,439